Sergio Traversa - 08 Dec 2022 Form 4 Insider Report for RELMADA THERAPEUTICS, INC. (RLMD)

Role: Chief Executive Officer, Director
Signature: /s/ Sergio Traversa
Issuer symbol: RLMD
Transactions as of: 08 Dec 2022
Net transactions value: +$115,804
Form type: 4
Filing time: 12 Dec 2022, 19:00:42 UTC
Previous filing: 05 Jul 2022
Next filing: 20 Dec 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RLMD	Common Stock	Purchase	$115,804	+55,250	+62%	$2.10	144,024	08 Dec 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range.
F2	Purchase prices range from $2.05 to $2.13 per share, inclusive.

Content

The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range.

Purchase prices range from $2.05 to $2.13 per share, inclusive.